Kozak & Associates, Inc. Electro Core, Inc. Transaction History

Kozak & Associates, Inc.

  • $414 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
BUY
$0.93 - $1.18 $9,300 - $11,800
10,000 New
10,000 $9,000

Others Institutions Holding ECOR

# of Institutions
3
Shares Held
143K
Call Options Held
0
Put Options Held
0
View Full List

About electroCore, Inc.

ECOR Quotes by TradingView
  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $1.09B
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Kozak & Associates, Inc. Portfolio

Follow Kozak & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kozak & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kozak & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email